Results 11 to 20 of about 860,145 (127)

The use of transpulmonary contrast echocardiography: A first experience in Serbia [PDF]

open access: yesVojnosanitetski Pregled, 2021
Background/Aim. Contrast echocardiography (CE) is an echocardiographic modality where ultrasound contrast echocardiographic agent (CEA) is introduced peripherally for the image enhancement.
Stojšić-Milosavljević Anastrazija   +13 more
doaj   +1 more source

Deep Learning Prediction of Adverse Drug Reactions Using Open TG-GATEs and FAERS Databases [PDF]

open access: yes, 2020
With the advancements in Artificial intelligence (AI) and the accumulation of healthrelated big data, it has become increasingly feasible and commonplace to leverage machine learning technologies to analyze clinical and omics metadata to assess the possibility of adverse drug reactions or events (ADRs) in the course of drug discovery.
arxiv   +1 more source

Suspected Adverse Drug Reactions Related to Breast Cancer Chemotherapy: Disproportionality Analysis of the Brazilian Spontaneous Reporting System

open access: yesFrontiers in Pharmacology, 2019
Spontaneous reporting systems may generate a large volume of information in real world conditions with a relatively low cost. Disproportionality measures are useful to indicate and quantify unexpected safety issues associated with a given drug-event pair
Flávia Campos Barcelos   +4 more
doaj   +1 more source

Identifying the incidence of rash, Stevens-Johnson syndrome and toxic epidermal necrolysis in patients taking lamotrigine: a systematic review of 122 randomized controlled trials [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2017
Lamotrigine is an antiepileptic drug used for the treatment of epilepsy, bipolar disorder and numerous off-label uses. The development of rash significantly affects its use. The most concerning of these adverse reactions is Stevens-Johnson syndrome/toxic
Romi Bloom, Kyle T. Amber
doaj   +2 more sources

Integrating pharmacovigilance into the routine of pharmacy department: experience of nine years [PDF]

open access: yesFarmacia Hospitalaria, 2019
Objective: To describe our pharmacovigilance program and to analyze the reported adverse drug reactions. Method: Observational longitudinal study conducted from 2008 to 2016.
Ariadna Pérez-Ricart   +4 more
doaj   +1 more source

Delayed angioedema during therapy with angiotensin-converting enzyme inhibitors [PDF]

open access: yesVojnosanitetski Pregled, 2011
Introduction. Angiotensin-converting enzyme inhibitors are leading cause of drug-induced angioedema, with incidence of 0.1 to 0.2%. The angioedema is not of immune nature; in predisposed individuals it is caused by accumulation of vasoactive mediators
Janković Slobodan M.   +1 more
doaj   +1 more source

Nurses' reporting of suspect adverse drug reactions: a mixed-methods study

open access: yesAnnali dell'Istituto Superiore di Sanità, 2015
OBJECTIVE: To assess nurses' knowledge, attitudes and practices (KAP) towards spontaneous adverse drug reactions (ADRs) reporting. METHODS: The mixed-method study was conducted following a quanti-qualitative sequential approach: a survey (using a KAP ...
Alessia De Angelis   +4 more
doaj   +1 more source

Potential kidney damage associated with the use of remdesivir for COVID-19: analysis of a pharmacovigilance database

open access: yesCadernos de Saúde Pública, 2021
: The U.S. Food and Drug Administration (FDA) has stated that the prescription of remdesivir should be cautious for patients with estimated glomerular filtration rate (eGFR) < 30 and some studies reported risk of adverse renal events.
Nayara Aparecida de Oliveira Silva   +3 more
doaj   +1 more source

DEVELOPING A CHALLENGES LANDSCAPE RELATING TO DRUG SAFETY, PROVISION, AND DISTRIBUTION IN RESOURCE-LIMITED SETTINGS FOR THE CASE OF HIV/AIDS

open access: yesSouth African Journal of Industrial Engineering, 2018
Since 2010, pharmaceutical organisations have begun to provide drug patents in sub-Saharan Africa through the UN Medicine Patent Pool. This initiative allows any pharmaceutical manufacturer to access these patents and manufacture the drugs, thereby ...
Huysamen, Biance   +2 more
doaj   +1 more source

Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems

open access: yesTherapeutics and Clinical Risk Management, 2021
Nayoung Han,1,2 Jung Mi Oh,1,3 In-Wha Kim1 1Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea; 2College of Pharmacy, Jeju National University, Jejusi, Jeju Special Self-Governing Province, Republic of ...
Han N, Oh JM, Kim IW
doaj  

Home - About - Disclaimer - Privacy